KIAA1462 product was also designated JCAD (Junctional protein associated with coronary artery disease), which is a novel molecular component of VE-cadherin-based endothelial cell–cell junctions [3], and was identified by restriction site-associated DNA (RAD) sequencing [4]. This evidence concerns the gene JCAD and coronary artery disorder.